GGrantIndex
Sort

21,281 grants matching influenza

Influenza Viral Pathogenesis

$2,517,484
Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

University of Washington Vaccine and Treatment Evaluation Unit

$2,516,717
Anna Wald · University Of Washington · UM1 · FY2021 · AI

DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES

$2,515,245
David Burkhart · Inimmune Corporation · N01 · FY2024 · AI

Pandemic Influenza Translational Research; Novel Vaccine and Drug Therapy

$2,514,389
Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Development of Broadly Immunogenic and Universal Influenza Virus Vaccines

$2,513,196
Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Research Initiatives on COVID-19 in the Division of Translational Toxicology

$2,512,425
Dori R Germolec · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES

Computational Models of Infectious Disease Threats

$2,510,605
Donald S. Burke · University Of Pittsburgh At Pittsburgh · U54 · FY2012 · GM

Programming Long-lasting Immunity to Coronaviruses (PLUTO)

$2,506,857
Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AI

BSL3 management and practice of infectious disease research at HTRL

$2,506,378
Dominique M Missiakas · University Of Chicago · UC7 · FY2025 · AI

Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center

$2,506,053
Richard G Wunderink · Northwestern University At Chicago · U19 · FY2023 · AI

Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core

$2,501,263
Chip Walter · Duke University · N01 · FY2024 · AI

Center for Statistics and Quantitative Infectious Diseases

$2,500,411
M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2018 · GM

Center for Statistics and Quantitative Infectious Diseases

$2,500,411
M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2014 · GM

Center for Statistics and Quantitative Infectious Diseases

$2,500,411
M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2016 · GM

Center for Statistics and Quantitative Infectious Diseases

$2,500,411
M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2017 · GM

Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific

$2,500,000
Benjamin John Cowling · University Of Hong Kong · U01 · FY2019 · IP

GCR: Understanding Virus Evolution Through Deep Raman Spectroscopy

$2,500,000
Mauricio Terrones · Pennsylvania State Univ University Park · · FY2019 · ENG

US-China Collab: Harnessing Big Data to understand and predict diversity and transmission of human- and animal-infected avian influenza viruses in China

$2,500,000
Xiangming Xiao · University Of Oklahoma Norman Campus · · FY2020 · BIO

Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens

$2,500,000
Myron Max Levine · University Of Maryland Baltimore · U19 · FY2019 · AI

Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens

$2,500,000
Myron Max Levine · University Of Maryland Baltimore · U19 · FY2021 · AI

Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens

$2,500,000
Myron Max Levine · University Of Maryland Baltimore · U19 · FY2022 · AI

Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens

$2,500,000
Myron Max Levine · University Of Maryland Baltimore · U19 · FY2023 · AI

RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations

$2,500,000
Vel Murugan · Arizona State University-Tempe Campus · U01 · FY2022 · IP

Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens

$2,500,000
Myron Max Levine · University Of Maryland Baltimore · U19 · FY2020 · AI

Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific

$2,500,000
Benjamin John Cowling · University Of Hong Kong · U01 · FY2020 · IP